Bozic Carmen 4

What Happened
Carmen Bozic, EVP and Chief Medical Officer of Vertex Pharmaceuticals (VRTX), sold 2,329 shares on 2026-03-13 at $481.79 per share, generating proceeds of $1,122,089. The filing lists the sale as an open-market or private sale and identifies it as a sale (S), which is typically a routine disposition rather than a direct bullish signal.

Key Details

• Transaction date: 2026-03-13; Filing date: 2026-03-17 (filed within the required reporting window).
• Price per share: $481.79; Total proceeds: $1,122,089.
• Shares owned after transaction: Not disclosed in the information provided on the Form 4.
• Footnote: The sale was made pursuant to a company-approved Rule 10b5-1 trading plan entered into on 2025-11-20.
• Transaction code: S = Sale.

Context
Sales executed under a 10b5-1 plan are pre-set trading arrangements that allow insiders to sell shares according to a predefined schedule; they are generally viewed as routine and do not necessarily reflect current insider views on the company. For retail investors, purchases by insiders are often considered more informative than scheduled sales.